Citizens Financial Group’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-187
Closed -$2K 1230
2020
Q1
$2K Hold
187
﹤0.01% 1052
2019
Q4
$5K Buy
+187
New +$3.79K ﹤0.01% 880

Other funds holding XENT

Citizens Financial Group's XENT Position: Q2 2020 in Review

Citizens Financial Group sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 187 shares — an estimated $2K sold.

Citizens Financial Group first reported a position in XENT in Q4 2019 and held it in 2 quarters. The position peaked at $5K in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • Citizens Financial Group reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • Citizens Financial Group sold 187 Intersect ENT, Inc shares in Q2 2020, an estimated $2K.
  • Citizens Financial Group first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 2 quarters.
  • Citizens Financial Group's Intersect ENT, Inc position peaked at $5K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Citizens Financial Group's 13F filing for Q2 2020, filed 12 Aug 2020.